SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #482CAS 1区Top JournalReview JournalHybrid

Cancer Treatment Reviews

Abbreviation (ISO):CANCER TREAT REV
Country: England•WoS SCIE Quartile: Q1•Scopus SJR: 3.745•SCImago Rank: #482•Identifier (ISSN):0305-7372(Print)/1532-1967(Online)•Articles / Year: 108•Estimated Publication Fee (APC): $4,233 USD
Clarivate IF (2026)Q1
10.6
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
116

116 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
108articles/year
37.12% Gold OA•0% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 10.6)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.6)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.5)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 9.6)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.8)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 13.608)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 12.111)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.885)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.332)
🔵 Computed
20183.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.122)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Cancer Treatment Reviews Welcome to the online submission and editorial system for Cancer Treatment Reviews. Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews. Each issue provides topical reviews under the following regular sections: • comments on controversy • tumor reviews • anti-tumor treatments • new drugs • complications of treatment • general and supportive care • laboratory/clinic interface.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsOncology & Cancer ResearchOncologyPathologySurgeryChemistryBiochemistryCancer ResearchImmunologyPhysicsBioinformatics
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #482Scopus Q1SCImago Profile
Scopus Coverage:1974-1991, 1993-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
3.745

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
180

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
10.64

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,233 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations3,538
3-Year Documents308
Citable Documents305

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
OncologyQ1
Radiology, Nuclear Medicine and ImagingQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
3.6周
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
W.B. Saunders Ltd
Publication Language
English
Frequency
Quarterly
Founding Year
1974
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
34/333Q1
ONCOLOGY
JCISCIE
53/333Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—8473
202510.51361,192
20249.61322,338
202311.81073,159
202213.6081105,117
202112.1111216,186
20208.88511610,074
20198.332866,605
20188.12214411,552
2017—13913,975
2016—12812,648
2015—11710,524
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cancer Treatment Reviews

WoS Q1
5912162018201920202021202220232024202510.50
Annual Impact Factor Metric
2025:10.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

ESMO Open
IF: 10.6Q1
100% MatchExplore →
Liver Cancer
IF: 10.5Q1
100% MatchExplore →
Record UUID: 46bf748c-da38-4955-8d9b-585c6bed900d
Database Updated: 2026-09-28